The effects of four-week supplementation of Lion’s mane and a Lion’s mane and Reishi blend on prioritised mood and wellbeing measures in young women
- 1Brain, Performance and Nutrition Research Centre, School of Psychology, Northumbria University , ,
- 2School of Psychology, Northumbria University , ,
Abstract
Background: Functional mushrooms, particularly Lion’s mane (Hericium erinaceus) and Reishi (Ganoderma lucidum), are increasingly marketed for cognitive and mood-related benefits, despite limited evidence to date.
Objectives: This trial examined the effects of four-week supplementation of Lion’s mane and a Lion’s mane and Reishi mushroom blend on mood and wellbeing in Gen Z women experiencing subjective stress and/or anxiety.
Methods: A preliminary sort-and-rank study was conducted to identify priority outcomes for the population. Following this, a randomised, double-blind, placebo-controlled, parallel-groups trial was conducted. Eighty-four young women (aged 18–26) received either 1.8 g powdered Lion’s mane, 1.8 g powdered Lion’s mane and Reishi mushroom blend, or placebo in capsulated form for 28-days. Mood and wellbeing were assessed at baseline, weekly during the intervention period and at Day 42 (follow-up). Qualitative data regarding subjective changes to wellbeing were collected on Days 28 and 42.
Results: Analysis indicated that the mushroom blend resulted in lower anxiety (GAD-7) than Lion’s Mane, overall (p = 0.018) and at Day 28 (p = 0.003). Following FDR correction, secondary interactions for anxiety (HADS) and stress (PSS) were attenuated to trend-level, exploratory post hoc tests suggested a pattern of benefits of the mushroom blend over Lion’s mane and placebo at various timepoints (p = 0.001–0.043), though these should be interpreted cautiously rather than confirmatory. Qualitative data supported this pattern. Significant improvements across all psychological measures were observed regardless of treatment allocation, suggesting participatory benefits alongside intervention effects.
Conclusion: Results indicated that 28-day supplementation with the mushroom-blend improved the primary anxiety outcome (GAD-7), relative to Lion’s mane alone. Trend-level findings on secondary anxiety (HADS) and stress (PSS) measures point to a similar pattern of benefit over both comparators, but require confirmation in adequately powered trials. This trial contributes to a growing field investigating functional mushrooms, however, to further understand efficacy effects, substantial work is required to determine key methodological questions including dosage, intervention duration and blend composition.
Clinical trial registration: ClinicalTrials.gov, identifier NCT06406946.
Related
- Barriers, facilitators, and prioritised service-improvement suggestions across the breast and cervical cancer screening journey: a two-phase exploratory study in rural multi-ethnic northwestern China
- Soy Consumption and the Risk of Developing Bladder Cancer: A Pooled Analysis of Cohort Studies from the International Pooled Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) Study
- Aloe vera-PDMS blend thin films with combined triboelectric and polarization mechanisms for wearable energy harvesting
- Six-Month Changes in BMI, Menstrual-Cycle Characteristics, and Ferriman-Gallwey Scores Associated With a Multi-ingredient Nutritional Supplement Blend in Women With PCOS: A Prospective Observational Study
- Editorial: 15 years of frontiers in psychiatry – wellbeing and society
BibTeX
@article{smith2026effects,
title = {{The effects of four-week supplementation of Lion’s mane and a Lion’s mane and Reishi blend on prioritised mood and wellbeing measures in young women}},
author = {Ellen F. Smith and Sarah Docherty},
journal = {Frontiers in nutrition},
year = {2026},
month = oct,
doi = {10.3389/fnut.2026.1887408},
url = {https://europepmc.org/article/PMC/PMC13727649},
note = {CC BY},
}
RIS
TY - JOUR
TI - The effects of four-week supplementation of Lion’s mane and a Lion’s mane and Reishi blend on prioritised mood and wellbeing measures in young women
AU - Ellen F. Smith
AU - Sarah Docherty
PY - 2026
DA - 2026/10/20
JO - Frontiers in nutrition
DO - 10.3389/fnut.2026.1887408
UR - https://europepmc.org/article/PMC/PMC13727649
AB - Background: Functional mushrooms, particularly Lion’s mane (Hericium erinaceus) and Reishi (Ganoderma lucidum), are increasingly marketed for cognitive and mood-related benefits, despite limited evidence to date. Objectives: This trial examined the effects of four-week supplementation of Lion’s mane and a Lion’s mane and Reishi mushroom blend on mood and wellbeing in Gen Z women experiencing subjective stress and/or anxiety. Methods: A preliminary sort-and-rank study was conducted to identify priority outcomes for the population. Following this, a randomised, double-blind, placebo-controlled, parallel-groups trial was conducted. Eighty-four young women (aged 18–26) received either 1.8 g powdered Lion’s mane, 1.8 g powdered Lion’s mane and Reishi mushroom blend, or placebo in capsulated form for 28-days. Mood and wellbeing were assessed at baseline, weekly during the intervention period and at Day 42 (follow-up). Qualitative data regarding subjective changes to wellbeing were collected on Days 28 and 42. Results: Analysis indicated that the mushroom blend resulted in lower anxiety (GAD-7) than Lion’s Mane, overall (p = 0.018) and at Day 28 (p = 0.003). Following FDR correction, secondary interactions for anxiety (HADS) and stress (PSS) were attenuated to trend-level, exploratory post hoc tests suggested a pattern of benefits of the mushroom blend over Lion’s mane and placebo at various timepoints (p = 0.001–0.043), though these should be interpreted cautiously rather than confirmatory. Qualitative data supported this pattern. Significant improvements across all psychological measures were observed regardless of treatment allocation, suggesting participatory benefits alongside intervention effects. Conclusion: Results indicated that 28-day supplementation with the mushroom-blend improved the primary anxiety outcome (GAD-7), relative to Lion’s mane alone. Trend-level findings on secondary anxiety (HADS) and stress (PSS) measures point to a similar pattern of benefit over both comparators, but require confirmation in adequately powered trials. This trial contributes to a growing field investigating functional mushrooms, however, to further understand efficacy effects, substantial work is required to determine key methodological questions including dosage, intervention duration and blend composition. Clinical trial registration: ClinicalTrials.gov, identifier NCT06406946.
SN - 2296-861X
ER -